DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Nalluri SR. et al.
Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis.
J Am Med Assoc 2008;
300: 2277-2285.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.